Skip to content
Medium cut-off hemodialysis in multiple myeloma-associated cast nephropathy: A single-center experience
All contributors

Onconephrology contributor

Zafrani, Lara

Primarily Tumor lysis & electrolytes#41 of 47 recognized
  • #2 in Tumor lysis & electrolytes
8
Clinical papers
307
Citations (iCite)
0 / 5
First / senior author
2013–2024
Active years

Output over time

Clinical corpus papers per year — peak 3 in 2022.

  • 2013: 1 paper
  • 2014: 1 paper
  • 2015: 1 paper
  • 2018: 1 paper
  • 2022: 3 papers
  • 2024: 1 paper
20132024

Subfield mix

Clinical papers by onconephrology subfield (a paper can count in more than one).

Tumor lysis & electrolytes6
Anticancer drug nephrotoxicity4
Cellular therapy renal effects2

Frequent collaborators

Other recognized contributors who most often share corpus papers with Zafrani (shared-paper count).

Azoulay, Elie5

Verify

Representative recent papers, and this author’s full PubMed bibliography.

PMID 36220698 (opens PubMed in a new tab)PMID 36552755 (opens PubMed in a new tab)PMID 35523579 (opens PubMed in a new tab)PMID 35207375 (opens PubMed in a new tab)PMID 29579262 (opens PubMed in a new tab)PMID 25480521 (opens PubMed in a new tab)All papers on PubMed

A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,329-article corpus (regenerated 2026-08-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.